171 related articles for article (PubMed ID: 23624022)
1. Evaluation of an in silico cardiac safety assay: using ion channel screening data to predict QT interval changes in the rabbit ventricular wedge.
Beattie KA; Luscombe C; Williams G; Munoz-Muriedas J; Gavaghan DJ; Cui Y; Mirams GR
J Pharmacol Toxicol Methods; 2013; 68(1):88-96. PubMed ID: 23624022
[TBL] [Abstract][Full Text] [Related]
2. Simulation of multiple ion channel block provides improved early prediction of compounds' clinical torsadogenic risk.
Mirams GR; Cui Y; Sher A; Fink M; Cooper J; Heath BM; McMahon NC; Gavaghan DJ; Noble D
Cardiovasc Res; 2011 Jul; 91(1):53-61. PubMed ID: 21300721
[TBL] [Abstract][Full Text] [Related]
3. Suppression of phosphoinositide 3-kinase signaling and alteration of multiple ion currents in drug-induced long QT syndrome.
Lu Z; Wu CY; Jiang YP; Ballou LM; Clausen C; Cohen IS; Lin RZ
Sci Transl Med; 2012 Apr; 4(131):131ra50. PubMed ID: 22539774
[TBL] [Abstract][Full Text] [Related]
4. Electrophysiological Changes in the Rabbit Ventricular Wedge and Human-Induced Pluripotent Stem-Cell Derived (IPSC) Cardiomyocytes Translate to Severe Arrhythmia Observed in a Canine Toxicology Study, Not Predicted by Standard In Vitro Ion Channel Assays.
Brown AP; Friedrichs GS; Tang HM; Traebert M; Weber V; Yao N; Yan GX
Int J Toxicol; 2024; 43(3):231-242. PubMed ID: 38327194
[TBL] [Abstract][Full Text] [Related]
5. Nonclinical cardiovascular safety of pitolisant: comparing International Conference on Harmonization S7B and Comprehensive in vitro Pro-arrhythmia Assay initiative studies.
Ligneau X; Shah RR; Berrebi-Bertrand I; Mirams GR; Robert P; Landais L; Maison-Blanche P; Faivre JF; Lecomte JM; Schwartz JC
Br J Pharmacol; 2017 Dec; 174(23):4449-4463. PubMed ID: 28941245
[TBL] [Abstract][Full Text] [Related]
6. hERG subunit composition determines differential drug sensitivity.
Abi-Gerges N; Holkham H; Jones EM; Pollard CE; Valentin JP; Robertson GA
Br J Pharmacol; 2011 Sep; 164(2b):419-32. PubMed ID: 21449979
[TBL] [Abstract][Full Text] [Related]
7. ICH S7B In Vitro Assays Do Not Address Mechanisms of QT
Wu WW; Choe M; Johannesen L; Vicente J; Bende G; Stockbridge NL; Strauss DG; Garnett C
Clin Pharmacol Ther; 2023 Dec; 114(6):1332-1341. PubMed ID: 37702218
[TBL] [Abstract][Full Text] [Related]
8. A rabbit Langendorff heart proarrhythmia model: predictive value for clinical identification of Torsades de Pointes.
Lawrence CL; Bridgland-Taylor MH; Pollard CE; Hammond TG; Valentin JP
Br J Pharmacol; 2006 Dec; 149(7):845-60. PubMed ID: 17031389
[TBL] [Abstract][Full Text] [Related]
9. Ginsenoside Rg3 Alleviates Antithyroid Cancer Drug Vandetanib-Induced QT Interval Prolongation.
Zhang J; Luo D; Li F; Li Z; Gao X; Qiao J; Wu L; Li M
Oxid Med Cell Longev; 2021; 2021():3520034. PubMed ID: 34659631
[TBL] [Abstract][Full Text] [Related]
10. Reducing QT liability and proarrhythmic risk in drug discovery and development.
Valentin JP
Br J Pharmacol; 2010 Jan; 159(1):5-11. PubMed ID: 20141515
[TBL] [Abstract][Full Text] [Related]
11.
Boulay E; Troncy E; Jacquemet V; Huang H; Pugsley MK; Downey AM; Venegas Baca R; Authier S
Int J Toxicol; 2024 Mar; ():10915818241237988. PubMed ID: 38477622
[No Abstract] [Full Text] [Related]
12. Translating QT interval prolongation from conscious dogs to humans.
Dubois VF; Smania G; Yu H; Graf R; Chain AS; Danhof M; Della Pasqua O; ;
Br J Clin Pharmacol; 2017 Feb; 83(2):349-362. PubMed ID: 27614058
[TBL] [Abstract][Full Text] [Related]
13. Predicting the cardiac toxicity of drugs using a novel multiscale exposure-response simulator.
Sahli Costabal F; Yao J; Kuhl E
Comput Methods Biomech Biomed Engin; 2018 Feb; 21(3):232-246. PubMed ID: 29493299
[TBL] [Abstract][Full Text] [Related]
14. Testing the nonclinical Comprehensive In Vitro Proarrhythmia Assay (CiPA) paradigm with an established anti-seizure medication: Levetiracetam case study.
Delaunois A; Mathy FX; Cornet M; Gryshkova V; Korlowski C; Bonfitto F; Koch J; Schlit AF; Hebeisen S; Passini E; Rodriguez B; Valentin JP
Pharmacol Res Perspect; 2023 Feb; 11(1):e01059. PubMed ID: 36748725
[TBL] [Abstract][Full Text] [Related]
15. Effects of mixed herbal extracts from parched Puerariae radix, gingered Magnoliae cortex, Glycyrrhizae radix and Euphorbiae radix (KIOM-79) on cardiac ion channels and action potentials.
Park SJ; Choi KS; Shin DH; Kim JS; Jang DS; Youm JB; Choe H; Earm YE; Kim SJ
J Korean Med Sci; 2009 Jun; 24(3):403-12. PubMed ID: 19543501
[TBL] [Abstract][Full Text] [Related]
16. Machine learning in drug development: Characterizing the effect of 30 drugs on the QT interval using Gaussian process regression, sensitivity analysis, and uncertainty quantification.
Costabal FS; Matsuno K; Yao J; Perdikaris P; Kuhl E
Comput Methods Appl Mech Eng; 2019 May; 348():313-333. PubMed ID: 32863454
[TBL] [Abstract][Full Text] [Related]
17. Drug-induced QT interval shortening: potential harbinger of proarrhythmia and regulatory perspectives.
Shah RR
Br J Pharmacol; 2010 Jan; 159(1):58-69. PubMed ID: 19563537
[TBL] [Abstract][Full Text] [Related]
18. Effects of 4-Aminopyridine on Cloned hERG Channels Expressed in Mammalian Cells.
Renganathan M; Sidach S; Blight AR
Arch Drug Inf; 2009 Sep; 2(3):51-57. PubMed ID: 19915712
[TBL] [Abstract][Full Text] [Related]
19.
Hwang M; Lim CH; Leem CH; Shim EB
APL Bioeng; 2020 Jun; 4(2):021502. PubMed ID: 32548538
[TBL] [Abstract][Full Text] [Related]
20. Novel approaches to assessing cardiac safety--proceedings of a workshop: regulators, industry and academia discuss the future of in silico cardiac modelling to predict the proarrhythmic safety of drugs.
Fletcher K; Shah RR; Thomas A; Tobin F; Rodriguez B; Mirams GR; Saiz J; Noble D
Drug Saf; 2011 May; 34(5):439-43. PubMed ID: 21513366
[No Abstract] [Full Text] [Related]
[Next] [New Search]
